Atlas Trials

Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

Clinical trial NCT02893540 · UNKNOWN

Trial details

NCT number
NCT02893540
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2016-09-01
Primary completion
2018-12-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.